Hospice News November 28, 2022
Regulatory attention heating up in the hospice industry could be impacting buyers’ mergers and acquisitions decisions.
Nuances in the regulatory environment can be difficult to navigate, perhaps more so for private equity and venture capital investors that are new to the industry. Changes to federal enforcement practices during the next year could bring some additional pressure, according to Erin Burns, senior associate at health care law firm Husch Blackwell.
“Hospice transactions are more complicated than just your average business deal,” Burns said in a recent Husch Blackwell podcast. “On the corporate side of things, they can sometimes be 10 steps ahead and have not given thought to the regulatory considerations, which can put some time constraints on your deal...
Today's Sponsors
Today's Sponsor